ImmunologybioRxivPreprint
Development and pre-clinical evaluation of Newcastle disease virus-vectored SARS-CoV-2 intranasal vaccine candidate
M. Fernandez-Diaz, K. Calderon, A. Rojas-Neyra…·Salguedo-Bohorqu
This paper develops and evaluates an NDV-vectored SARS-CoV-2 intranasal vaccine candidate, showing safety, immunogenicity, and efficacy in animal models.